ONCO

Onconetix, Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$3.08

Price (1 Year)

$1,390 $3.03

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %3.7 / %30
Non-compliant assets / Total market cap %0 / %30
Non-compliant revenue / Total income %0 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer.

Website

Analysis (Turkish): ONCO Hissesi Caiz mi, Helal mi? Onconetix, Inc. Katılım Analizi